Literature DB >> 2775629

Drug treatment of intermittent claudication.

K H Labs.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2775629      PMCID： PMC1379910          DOI： 10.1111/j.1365-2125.1989.tb05421.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.

Authors:  H A Cameron; P C Waller; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

2.  Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.

Authors:  J M Porter; B S Cutler; B Y Lee; T Reich; F A Reichle; J T Scogin; D E Strandness
Journal:  Am Heart J       Date:  1982-07       Impact factor: 4.749

3.  Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.

Authors:  B Accetto
Journal:  Am Heart J       Date:  1982-05       Impact factor: 4.749

4.  Another look at the pentoxifylline efficacy data for intermittent claudication.

Authors:  D Gillings; G Koch; T Reich; W J Stager
Journal:  J Clin Pharmacol       Date:  1987-08       Impact factor: 3.126

5.  On the assessment of the efficacy of pentoxifylline (Trental).

Authors:  M Rössner; R Müller
Journal:  J Med       Date:  1987
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.